{"status": "OK", "response": {"docs": [{"type_of_material": "News", "blog": [], "news_desk": "Science", "lead_paragraph": "Scientists are experimenting with a new procedure to reduce high blood pressure in patients who do not respond to medication.", "headline": {"seo": "Experimental Surgery Targets Stubbornly High Blood Pressure", "main": "To Cut Blood Pressure, Nerves Get a Jolt", "print_headline": "To Cut Blood Pressure, Nerves Get a Jolt"}, "abstract": "Doctors are experimenting with a new electrical procedure to treat high blood pressure in patients who are resistant to standard treatments; procedure involves pulses of radio-frequency energy that are delivered to the arteries leading to a patient's kidney.", "print_page": "6", "word_count": "959", "_id": "515b5251fdc59278db00814e", "snippet": "Scientists are experimenting with a new procedure to reduce high blood pressure in patients who do not respond to medication.", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2012/06/12/science/experimental-surgery-targets-stubbornly-high-blood-pressure.html", "multimedia": [{"subtype": "xlarge", "url": "images/2012/06/12/science/12BLOOD_SPAN/12Blood-articleLarge.jpg", "height": 360, "width": 600, "legacy": {"xlargewidth": "600", "xlarge": "images/2012/06/12/science/12BLOOD_SPAN/12Blood-articleLarge.jpg", "xlargeheight": "360"}, "type": "image"}, {"subtype": "thumbnail", "url": "images/2012/06/12/science/12BLOOD_SPAN/12Blood-thumbStandard.jpg", "height": 75, "width": 75, "legacy": {"thumbnailheight": "75", "thumbnail": "images/2012/06/12/science/12BLOOD_SPAN/12Blood-thumbStandard.jpg", "thumbnailwidth": "75"}, "type": "image"}], "subsection_name": null, "keywords": [{"value": "Blood Pressure", "is_major": "Y", "rank": "1", "name": "subject"}, {"value": "Hypertension", "is_major": "N", "rank": "2", "name": "subject"}, {"value": "Drugs (Pharmaceuticals)", "is_major": "N", "rank": "3", "name": "subject"}, {"value": "Medicine and Health", "is_major": "N", "rank": "4", "name": "subject"}], "byline": {"contributor": "", "person": [{"organization": "", "role": "reported", "rank": 1, "firstname": "Amanda", "lastname": "SCHAFFER"}], "original": "By AMANDA SCHAFFER"}, "document_type": "article", "pub_date": "2012-06-12T00:00:00Z", "section_name": "Science"}, {"type_of_material": "Op-Ed", "blog": [], "news_desk": "OpEd", "lead_paragraph": "Seeing too much of ourselves in other animals might not be the problem we think it is. Underappreciating our own animal natures may be the greater limitation.", "headline": {"main": "Our Animal Natures", "kicker": "Opinion", "print_headline": "Our Animal Natures", "content_kicker": "Opinion"}, "abstract": "Op-Ed article by cardiology Prof Barbara Natterson-Horowitz and author Kathryn Bowers, adapted from their book Zoobiquity: What Animals Can Teach Us About Health and the Science of Healing, highlights the commonalities between humans and other animals; outlines what these commonalities, which they have observed by working with veterinarians, could mean for the treatment of human illnesses.", "print_page": "1", "word_count": "4379", "_id": "515a3c79fdc59278db00269f", "snippet": "Seeing too much of ourselves in other animals might not be the problem we think it is. Underappreciating our own animal natures may be the greater limitation.", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2012/06/10/opinion/sunday/our-animal-natures.html", "multimedia": [{"subtype": "wide", "url": "images/2012/06/10/sunday-review/10COVER/10COVER-thumbWide.jpg", "height": 126, "width": 190, "legacy": {"wide": "images/2012/06/10/sunday-review/10COVER/10COVER-thumbWide.jpg", "wideheight": "126", "widewidth": "190"}, "type": "image"}, {"subtype": "xlarge", "url": "images/2012/06/10/sunday-review/10COVER/10COVER-articleLarge-v2.jpg", "height": 421, "width": 600, "legacy": {"xlargewidth": "600", "xlarge": "images/2012/06/10/sunday-review/10COVER/10COVER-articleLarge-v2.jpg", "xlargeheight": "421"}, "type": "image"}, {"subtype": "thumbnail", "url": "images/2012/06/10/sunday-review/10COVER/10COVER-thumbStandard.jpg", "height": 75, "width": 75, "legacy": {"thumbnailheight": "75", "thumbnail": "images/2012/06/10/sunday-review/10COVER/10COVER-thumbStandard.jpg", "thumbnailwidth": "75"}, "type": "image"}], "subsection_name": "Sunday Review", "keywords": [{"value": "Animals", "is_major": "N", "rank": "1", "name": "subject"}, {"value": "Addiction (Psychology)", "is_major": "N", "rank": "11", "name": "subject"}, {"value": "Veterinary Medicine", "is_major": "Y", "rank": "2", "name": "subject"}, {"value": "Medicine and Health", "is_major": "Y", "rank": "3", "name": "subject"}, {"value": "Cancer", "is_major": "N", "rank": "4", "name": "subject"}, {"value": "Obesity", "is_major": "N", "rank": "5", "name": "subject"}, {"value": "Drug Abuse and Traffic", "is_major": "N", "rank": "6", "name": "subject"}, {"value": "Research", "is_major": "N", "rank": "7", "name": "subject"}, {"value": "Mental Health and Disorders", "is_major": "N", "rank": "8", "name": "subject"}, {"value": "Books and Literature", "is_major": "Y", "rank": "9", "name": "subject"}], "byline": {"contributor": "", "person": [{"organization": "", "role": "reported", "rank": 1, "firstname": "Barbara", "lastname": "NATTERSON-HOROWITZ"}, {"organization": "", "role": "reported", "rank": 2, "firstname": "Kathryn", "lastname": "BOWERS"}], "original": "By BARBARA NATTERSON-HOROWITZ and KATHRYN BOWERS"}, "document_type": "article", "pub_date": "2012-06-10T00:00:00Z", "section_name": "Opinion"}, {"type_of_material": "News", "blog": [], "news_desk": "Business", "lead_paragraph": "The drug Perjeta is meant to be used with the company\u2019s drug called Herceptin to treat the disease its advanced stages.", "headline": {"seo": "Genentech Wins Approval For New Breast Cancer Drug", "main": "Genentech Wins Approval for New Breast Cancer Drug", "print_headline": "Genentech Breast Cancer Drug Wins Approval"}, "abstract": "Genentech wins federal approval for Perjeta, a new drug to treat advanced breast cancer; company announces that it is expecting manufacturing problems that could lead to a shortage of the drug.", "print_page": "6", "word_count": "628", "_id": "515b52bbfdc59278db0081bd", "snippet": "The drug Perjeta is meant to be used with the company\u2019s drug called Herceptin to treat the disease its advanced stages.", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2012/06/09/business/genentech-wins-approval-for-new-breast-cancer-drug.html", "multimedia": [], "subsection_name": null, "keywords": [{"value": "Drugs (Pharmaceuticals)", "is_major": "Y", "rank": "1", "name": "subject"}, {"value": "Breast Cancer", "is_major": "Y", "rank": "2", "name": "subject"}, {"value": "Herceptin (Drug)", "is_major": "N", "rank": "3", "name": "subject"}, {"value": "Genentech Inc", "is_major": "Y", "rank": "4", "name": "organizations"}, {"value": "Food and Drug Administration", "is_major": "N", "rank": "5", "name": "organizations"}], "byline": {"contributor": "", "person": [{"organization": "", "role": "reported", "rank": 1, "firstname": "Andrew", "lastname": "POLLACK"}], "original": "By ANDREW POLLACK"}, "document_type": "article", "pub_date": "2012-06-09T00:00:00Z", "section_name": "Business Day"}], "meta": {"hits": 3, "offset": 0, "time": 46}}, "copyright": "Copyright (c) 2013 The New York Times Company.  All Rights Reserved."}